1887

Abstract

IFN-antagonist function is a major determinant of pathogenicity and cross-species infection by viruses, but remains poorly defined for many potentially zoonotic viruses resident in animal species. The paramyxovirus family contains several zoonotic viruses, including highly pathogenic viruses such as Nipah virus and Hendra virus, and an increasing number of largely uncharacterized animal viruses. Here, we report the characterization of IFN antagonism by the rodent viruses J virus (JPV) and Beilong virus (BeiPV) of the proposed genus of the paramyxoviruses. Infection of cells by JPV and BeiPV was found to inhibit IFN-activated nuclear translocation of signal transducer and activator of transcription 1 (STAT1). However, in contrast to most other paramyxoviruses, the JPV and BeiPV V proteins did not interact with or inhibit signalling by STAT1 or STAT2, suggesting that JPV/BeiPV use an atypical V protein-independent strategy to target STATs, consistent with their inclusion in a separate genus. Nevertheless, the V proteins of both viruses interacted with melanoma differentiation-associated protein 5 (MDA5) and robustly inhibited MDA5-dependent activation of the IFN-β promoter. This supports a growing body of evidence that MDA5 is a universal target of paramyxovirus V proteins, such that the V–MDA5 interaction represents a potential target for broad-spectrum antiviral approaches.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000388
2016-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/3/581.html?itemId=/content/journal/jgv/10.1099/jgv.0.000388&mimeType=html&fmt=ahah

References

  1. Akira S. 2009; Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci 85:143–156 [View Article][PubMed]
    [Google Scholar]
  2. Andrejeva J., Young D. F., Goodbourn S., Randall R. E. 2002; Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76:2159–2167 [View Article][PubMed]
    [Google Scholar]
  3. Andrejeva J., Childs K. S., Young D. F., Carlos T. S., Stock N., Goodbourn S., Randall R. E. 2004; The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc Natl Acad Sci U S A 101:17264–17269 [View Article][PubMed]
    [Google Scholar]
  4. Audsley M. D., Moseley G. W. 2013; Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol 2:57–70 [View Article][PubMed]
    [Google Scholar]
  5. Bajorek M., Morita E., Skalicky J. J., Morham S. G., Babst M., Sundquist W. I. 2009; Biochemical analyses of human IST1 and its function in cytokinesis. Mol Biol Cell 20:1360–1373 [View Article][PubMed]
    [Google Scholar]
  6. Bowden T. R., Westenberg M., Wang L.-F., Eaton B. T., Boyle D. B. 2001; Molecular characterization of Menangle virus, a novel paramyxovirus which infects pigs, fruit bats, and humans. Virology 283:358–373 [View Article][PubMed]
    [Google Scholar]
  7. Caignard G., Guerbois M., Labernardière J. L., Jacob Y., Jones L. M., Wild F., Tangy F., Vidalain P. O., Infectious Mapping Project I-MAP. 2007; Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-α/β signaling. Virology 368:351–362 [View Article][PubMed]
    [Google Scholar]
  8. Caignard G., Lucas-Hourani M., Dhondt K. P., Labernardière J. L., Petit T., Jacob Y., Horvat B., Tangy F., Vidalain P. O. 2013; The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells. PLoS One 8:e53881 [View Article][PubMed]
    [Google Scholar]
  9. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., Randall R., Goodbourn S. 2007; mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190–200 [View Article][PubMed]
    [Google Scholar]
  10. Chinnakannan S. K., Nanda S. K., Baron M. D. 2013; Morbillivirus V proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways. PLoS One 8:e57063 [View Article][PubMed]
    [Google Scholar]
  11. Chinnakannan S. K., Holzer B., Bernardo B. S., Nanda S. K., Baron M. D. 2014; Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signalling. J Gen Virol 95:44–51 [View Article][PubMed]
    [Google Scholar]
  12. Devaux P., Hudacek A. W., Hodge G., Reyes-Del Valle J., McChesney M. B., Cattaneo R. 2011; A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J Virol 85:348–356 [View Article][PubMed]
    [Google Scholar]
  13. Gotoh B., Takeuchi K., Komatsu T., Yokoo J., Kimura Y., Kurotani A., Kato A., Nagai Y. 1999; Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses. FEBS Lett 459:205–210 [View Article][PubMed]
    [Google Scholar]
  14. Horvath C. M. 2004; Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem 271:4621–4628 [View Article][PubMed]
    [Google Scholar]
  15. Jack P. J., Boyle D. B., Eaton B. T., Wang L.-F. 2005; The complete genome sequence of J virus reveals a unique genome structure in the family Paramyxoviridae . J Virol 79:10690–10700 [View Article][PubMed]
    [Google Scholar]
  16. Jack P. J., Anderson D. E., Bossart K. N., Marsh G. A., Yu M., Wang L.-F. 2008; Expression of novel genes encoded by the paramyxovirus J virus. J Gen Virol 89:1434–1441 [View Article][PubMed]
    [Google Scholar]
  17. Joubert D. A., Blasdell K. R., Audsley M. D., Trinidad L., Monaghan P., Dave K. A., Lieu K. G., Amos-Ritchie R., Jans D. A., other authors. 2014; Bovine ephemeral fever rhabdovirus α1 protein has viroporin-like properties and binds importin β1 and importin 7. J Virol 88:1591–1603 [View Article][PubMed]
    [Google Scholar]
  18. Jun M. H., Karabatsos N., Johnson R. H. 1977; A new mouse paramyxovirus (J virus). Aust J Exp Biol Med Sci 55:645–647 [View Article][PubMed]
    [Google Scholar]
  19. Kubota T., Yokosawa N., Yokota S., Fujii N. 2001; C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon α and γ signal transduction pathway through decrease of STAT 1-α. Biochem Biophys Res Commun 283:255–259 [View Article][PubMed]
    [Google Scholar]
  20. Li Z., Yu M., Zhang H., Magoffin D. E., Jack P. J., Hyatt A., Wang H. Y., Wang L. F. 2006; Beilong virus, a novel paramyxovirus with the largest genome of non-segmented negative-stranded RNA viruses. Virology 346:219–228 [View Article][PubMed]
    [Google Scholar]
  21. Li Z., Xu J., Patel J., Fuentes S., Lin Y., Anderson D., Sakamoto K., Wang L.-F., He B. 2011; Function of the small hydrophobic protein of J paramyxovirus. J Virol 85:32–42 [View Article][PubMed]
    [Google Scholar]
  22. Lieu K. G., Marsh G. A., Wang L.-F., Netter H. J. 2015; The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2. Antiviral Res 124:69–76 [View Article][PubMed]
    [Google Scholar]
  23. Lin R., Génin P., Mamane Y., Hiscott J. 2000; Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20:6342–6353 [View Article][PubMed]
    [Google Scholar]
  24. Magoffin D. E., Mackenzie J. S., Wang L.-F. 2007; Genetic analysis of J-virus and Beilong virus using minireplicons. Virology 364:103–111 [View Article][PubMed]
    [Google Scholar]
  25. Manokaran G., Finol E., Wang C., Gunaratne J., Bahl J., Ong E. Z., Tan H. C., Sessions O. M., Ward A. M., other authors. 2015; Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350:217–221 [View Article][PubMed]
    [Google Scholar]
  26. Medzhitov R. 2007; Recognition of microorganisms and activation of the immune response. Nature 449:819–826 [View Article][PubMed]
    [Google Scholar]
  27. Moseley G. W., Lahaye X., Roth D. M., Oksayan S., Filmer R. P., Rowe C. L., Blondel D., Jans D. A. 2009; Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J Cell Sci 122:3652–3662 [View Article][PubMed]
    [Google Scholar]
  28. Motz C., Schuhmann K. M., Kirchhofer A., Moldt M., Witte G., Conzelmann K. K., Hopfner K. P. 2013; Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339:690–693 [View Article][PubMed]
    [Google Scholar]
  29. Nanda S. K., Baron M. D. 2006; Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 80:7555–7568 [View Article][PubMed]
    [Google Scholar]
  30. Nishio M., Tsurudome M., Ito M., Ito Y. 2005; Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol 79:14756–14768 [View Article][PubMed]
    [Google Scholar]
  31. Ohno S., Ono N., Takeda M., Takeuchi K., Yanagi Y. 2004; Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 85:2991–2999 [View Article][PubMed]
    [Google Scholar]
  32. Oksayan S., Ito N., Moseley G., Blondel D. 2012a; Subcellular trafficking in rhabdovirus infection and immune evasion: a novel target for therapeutics. Infect Disord Drug Targets 12:38–58 [View Article][PubMed]
    [Google Scholar]
  33. Oksayan S., Wiltzer L., Rowe C. L., Blondel D., Jans D. A., Moseley G. W. 2012b; A novel nuclear trafficking module regulates the nucleocytoplasmic localization of the rabies virus interferon antagonist, P protein. J Biol Chem 287:28112–28121 [View Article][PubMed]
    [Google Scholar]
  34. Palosaari H., Parisien J. P., Rodriguez J. J., Ulane C. M., Horvath C. M. 2003; STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77:7635–7644 [View Article][PubMed]
    [Google Scholar]
  35. Parisien J. P., Lau J. F., Horvath C. M. 2002; STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 76:6435–6441 [View Article][PubMed]
    [Google Scholar]
  36. Park M. S., Shaw M. L., Muñoz-Jordan J., Cros J. F., Nakaya T., Bouvier N., Palese P., García-Sastre A., Basler C. F. 2003; Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77:1501–1511 [View Article][PubMed]
    [Google Scholar]
  37. Ramachandran A., Horvath C. M. 2010; Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J Virol 84:11152–11163 [View Article][PubMed]
    [Google Scholar]
  38. Randall R. E., Goodbourn S. 2008; Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1–47[PubMed] [CrossRef]
    [Google Scholar]
  39. Rodriguez J. J., Parisien J. P., Horvath C. M. 2002; Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76:11476–11483 [View Article][PubMed]
    [Google Scholar]
  40. Rodriguez J. J., Wang L. F., Horvath C. M. 2003; Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77:11842–11845 [View Article][PubMed]
    [Google Scholar]
  41. Rodriguez J. J., Cruz C. D., Horvath C. M. 2004; Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 78:5358–5367 [View Article][PubMed]
    [Google Scholar]
  42. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B. G., Schoenemeyer A., Yamamoto M., Akira S., Fitzgerald K. A. 2005; The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175:5260–5268 [View Article][PubMed]
    [Google Scholar]
  43. Röthlisberger A., Wiener D., Schweizer M., Peterhans E., Zurbriggen A., Plattet P. 2010; Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import. J Virol 84:6328–6343 [View Article][PubMed]
    [Google Scholar]
  44. Schaap-Nutt A., D'Angelo C., Amaro-Carambot E., Nolan S. M., Davis S., Wise S. M., Higgins C., Bradley K., Kim O., other authors. 2010; Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates. Virology 406:65–79 [View Article][PubMed]
    [Google Scholar]
  45. Shaw M. L., García-Sastre A., Palese P., Basler C. F. 2004; Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78:5633–5641 [View Article][PubMed]
    [Google Scholar]
  46. Wiltzer L., Larrous F., Oksayan S., Ito N., Marsh G. A., Wang L.-F., Blondel D., Bourhy H., Jans D. A., Moseley G. W. 2012; Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. J Virol 86:10194–10199 [View Article][PubMed]
    [Google Scholar]
  47. Wiltzer L., Okada K., Yamaoka S., Larrous F., Kuusisto H. V., Sugiyama M., Blondel D., Bourhy H., Jans D. A., other authors. 2014; Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease. J Infect Dis 209:1744–1753 [View Article][PubMed]
    [Google Scholar]
  48. Woo P. C., Lau S. K., Wong B. H., Wu Y., Lam C. S., Yuen K. Y. 2012; Novel variant of Beilong paramyxovirus in rats, China. Emerg Infect Dis 18:1022–1024 [View Article][PubMed]
    [Google Scholar]
  49. Yie J., Senger K., Thanos D. 1999; Mechanism by which the IFN-β enhanceosome activates transcription. Proc Natl Acad Sci U S A 96:13108–13113 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000388
Loading
/content/journal/jgv/10.1099/jgv.0.000388
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error